malignant ascites

malignant ascites

Excess peritoneal fluid evoked by malignancy, which causes subdiaphragmatic lymphatic obstruction (e.g., of the thoracic duct) and increased intraperitoneal fluid production.

Clinical findings
Abdominal distension, weight gain, indigestion, dyspnea, orthopnea, tachypnoea, intestinal obstruction with nausea, vomiting.
 
Aetiology
Ovarian, breast, gastric, pancreatic, hepatic, and colorectal carcinomas, lymphoma, mesothelioma.
 
DiffDx
Tuberculosis, congestive heart failure, nephrotic syndrome, hepatic disease, bacterial peritonitis, malnutrition (due to hypoalbuminemia).
 
Management
Drainage of fluid, intraperitoneal chemotherapy, antibiotics, radioactive colloids, biological response modifiers (e.g., IL-2, alpha-IFN, external-beam radiation therapy), and surgical placement of LeVeen or Denver shunts.
 
Prognosis
Poor.

malignant ascites

Excess peritoneal fluid evoked by malignancy, which causes subdiaphragmatic lymphatic obstruction–eg, of the thoracic duct and ↑ intraperitoneal fluid production Etiology Ovarian, breast, gastric, pancreatic, hepatic, colorectal CA, lymphoma, mesothelioma Clinical Abdominal distension, weight gain, indigestion, dyspnea, orthopnea, tachypnea, intestinal obstruction with N&V Imaging Ground glass appearance, central positioning of small bowel loops, and obscured psoas sign on plain abdominal films; MA is confirmed with ultrasonography, CT, and MRI DiffDx TB, CHF, nephrotic syndrome, hepatic disease, bacterial peritonitis, malnutrition–due to hypoalbuminemia Management Drainage of fluid; intraperitoneal chemotherapy, antibiotics, radioactive colloids, biological response modifiers–eg, IL-2, α-IFN, external-beam RT, and surgical placement of LeVeen or Denver shunts Prognosis Poor
References in periodicals archive ?
won for its blow-molded 1,000ml PleurX Drainage Bottle (right), which automatically helps patients to safely and efficiently drain fluid buildup from recurrent pleural effusions and malignant ascites at home in only 5 to 15 minutes without the need for gravity.
Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.
Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
described a "port-site" tumor implant in a patient with malignant ascites 2 weeks following laparoscopy.
5mg/dl, spontaneous bacterial peritonitis, sepsis or variceal bleed within 7 days of LVP, hepatocellular carcinoma, platelet count less than 30,000 and malignant ascites.
Other programme highlights include presentations on 'The Unstable Patient', 'Infection Control', 'Ambulatory Care of Malignant Ascites and Pleural Effusion with Indwelling Catheters' and the Southland Wilderness Group giving a presentation on 'Wilderness Medicine'.
There will also be presentations on the unstable patient, infection control, ambulatory care of malignant ascites and pleural effusion with indwelling catheters.
The patient whose peritoneal fluid is illustrated in Figure 5, A and B, had stage IV pancreatic adenocarcinoma, with malignant ascites that had been diagnosed the previous month.
1,15) Patients with advanced disease may also present with a palpable gallbladder mass, hard nodular liver, and malignant ascites from carcinomatosis.
While originally evaluated for ascites in liver cirrhosis, the alfapump system has also been granted CE Mark for use in patients with malignant ascites (ascites caused by cancer).